Latest Breaking News On - Sound bioventures - Page 1 : comparemela.com

Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158

/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces.

United kingdomUnited statesArtax biopharmaJamesg kruegerRob armstrongCompany phaseAdvent life sciencesHead of the laboratory for investigative dermatologyPrnewswire artax biopharma incRockefeller universityEfficacy results are expectedSecond halfClass nck blockerAutoimmune diseaseBroad potentialTreat many autoimmune diseases

Breye Therapeutics Commences Oral Dosing of Danegaptide in Patients with Diabetic Retinopathy

Breye Therapeutics Commences Oral Dosing of Danegaptide in Patients with Diabetic Retinopathy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Wills eye hospitalUnited statesThomas jefferson universityCarl regilloUlrik mouritzenStefan klotterNovo holdingsProfessor of ophthalmology at thomas jefferson universityDanish innovation foundation innovationsfondenRetina service of wills eye hospitalBioinnovation instituteDanish growth foundationTherapeutics apsDiabetic retinopathyAge related macular degenerationChief executive officer

Breye Therapeutics ApS developing oral ophthalmology drugs

Patients with diabetic retinopathy as a result of diabetes, could benefit from a small molecule drug.

Wills eye hospitalUnited statesThomas jefferson universityCarl regilloUlrik mouritzenNovo holdingsDanish innovation foundation innovationsfondenDanish growth foundationBioinnovation instituteBreye therapeutics apsAge related macular degenerationBreye therapeuticsSound bioventuresDanish innovation foundationDrug deliveryOral drug delivery

Sound Bioventures appoints Fredrik Lehmann as its first

Stockholm, Sweden and Cambridge, MA, USA – 13 October 2023 - Sound Bioventures, a venture capital fund investing in about-to-be clinical or clinical stage.

United kingdomUnited statesFrazer hall markFredrik lehmannStockholm school of economicsBioventures fundOncopeptides as head of researchHead of researchManaging partnerSound bioventuresGeneral managerStockholm schoolSwedish alternative investment funds managers

Sound Bioventures appoints Fredrik Lehmann as its first Entrepreneur-in-Residence

Sound Bioventures appoints Fredrik Lehmann as its first Entrepreneur-in-Residence
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomFredrik lehmannFrazer hall markHead of researchOncopeptides as head of researchStockholm school of economicsBioventures fundManaging partnerSound bioventuresGeneral managerStockholm schoolSwedish alternative investment funds managers